Coronavirus therapeutics. Volume II, Clinical management and public health / edited by Alexzander A.A. Asea, Punit Kaur.
Asea, Alexzander A. A., editor; Kaur, Punit, editor
2021
RC772.V5 C67 2021
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title Coronavirus therapeutics. Volume II, Clinical management and public health / edited by Alexzander A.A. Asea, Punit Kaur.
ISBN 3030851133 (electronic book)
9783030851132 (electronic bk.)
3030851125
9783030851125
DOI https://doi.org/10.1007/978-3-030-85113-2
Published Cham, Switzerland : Springer, [2021]
Language English
Description 1 online resource
Item Number 10.1007/978-3-030-85113-2 doi
Call Number RC772.V5 C67 2021
Dewey Decimal Classification 616.2/414
616.9/1
Summary The book Coronavirus Therapeutics Volume II provides the most comprehensive review on contemporary knowledge on the consequences during the outbreak of Coronavirus. This also describes the clinical features, diagnostic evaluation and management of Coronavirus patients. Using an integrative approach to the understanding of paradigm gap in host-pathogen interaction studies to the management of Coronavirus patients in the Intensive Care Unit to the current challenges for the effective management of Coronavirus pandemic risk factors including diabetes, hypertension, obesity and repercussion on the central and peripheral nervous system. Key basic and clinical research laboratories from major universities, academic medical hospitals, biotechnology and pharmaceutical laboratories around the world have contributed articles that review present research activity on the role of heat shock proteins in human diseases and importantly project the field into the future. The book is a must read for graduate students. medical students, basic science researchers and postdoctoral scholars in the fields of Cancer Biology, Oncology, Cardiovascular Diseases, Microbiology, Inflammation, Translational Medicine, Clinical Research, Biotechnology, Cell & Molecular Medicine, Pharmaceutical Scientists and Researchers involved in Drug Discovery.
Access Note Access limited to authorized users.
Source of Description Online resource; title from digital title page (viewed on March 28, 2022).
Added Author Asea, Alexzander A. A., editor
Kaur, Punit, editor
Series Advances in experimental medicine and biology ; v. 1353.
Available in Other Form Coronavirus therapeutics. Volume II, Clinical management and public health.
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
Clinical features, diagnostic evaluation and management of COVID-19 patients
Outbreak of COVID-19: A Detailed Overview and Its Consequences
A paradigm gap in host-pathogen interaction studies: Lesson from the COVID-19 pandemic
SARS/CoV-2: Behavioral Host Manipulation
Management of COVID-19 in the Intensive Care Unit
First wave of Covid-19 pandemic in Italy: data and evidence
Risk factors for COVID-19: diabetes, hypertension and obesity
Current challenges for the effective management of the COVID-19 pandemic
COVID-19 Outbreak Challenges in Indian Migrant Pregnant and Lactating Mothers: Learnt Lesson Demands Phronesis and Hierarchical Strategies for Such Future Pandemics
COVID-19 and Extracorporeal Membrane Oxygenation
COVID-19's Clinical-Pathological Evidence in Relation to its Repercussion on the Central and Peripheral Nervous System
Anatomopathological Aspects and Clinical Correlation of COVID-19: A Systematic Review
SARS-CoV-2 liability: the hidden mystery behind its presentation in children.

Browse Subjects

Show more subjects...

Statistics

from
to
Export